Antibody samples: 10μl for 10 CHF!
For 10 CHF each, choose up to three samples from the selected 50 antibodies (changes every two months) and test them out!
Interested? Order by sending us the category number of your desired samples here:
Current selection valid from March 1st to April 30th, 2019.
Epithelial-mesenchymal transition (EMT) occurs when largely adherent and polarized epithelial cells acquire the phenotype of more mobile mesenchymal cells. EMT not only facilitates morphogenesis during embryonic development but also promotes invasion and metastasis in tumors. Pathological EMT is associated with E-cadherin repression, which contributes to tumor progression. Various oncogenic pathways (involving, for example, TGF-beta, Wnt/beta-catenin, integrins, and Notch) induce EMT via cytoskeletal rearrangement and activation of E-cadherin repressors, including SNAI1, SNAI2, SIP1, ZEB1, and TCF3.
Order by sending us the category number of your desired samples here: